MFS
NDRM

MSI Financial Services’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

MSI Financial Services’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-600
Closed -$12K – 4170
2015
Q3 		$12K Buy
+600
New +$12.3K ﹤0.01% 2017

Other funds holding NDRM

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

MSI Financial Services's NDRM Position: Q4 2015 in Review

MSI Financial Services sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2015, closing a stake of 600 shares — an estimated $12K sold.

MSI Financial Services first reported a position in NDRM in Q3 2015 and held it in 1 quarter. The position peaked at $12K in Q3 2015. 49 funds tracked by Wall St. Rank hold NDRM as of Q4 2015.

  • MSI Financial Services reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2015 after selling out during the quarter.
  • MSI Financial Services sold 600 NeuroDerm Ltd. Ordinary Shares shares in Q4 2015, an estimated $12K.
  • MSI Financial Services first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2015 and held it in 1 quarter.
  • MSI Financial Services's NeuroDerm Ltd. Ordinary Shares position peaked at $12K in Q3 2015.
  • 49 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2015.

Based on MSI Financial Services's 13F filing for Q4 2015, filed 4 Feb 2016.